Management of Delirium
Delirium management requires immediate identification and treatment of underlying medical causes while simultaneously implementing non-pharmacological interventions as first-line therapy, reserving antipsychotics only for moderate-to-severe symptoms or when behavioral disturbances pose safety risks. 1
Immediate Assessment and Diagnosis
- Use the Confusion Assessment Method (CAM) or its variants (3D-CAM, CAM-ICU, Brief CAM) to diagnose delirium, which has 82-100% sensitivity and 89-99% specificity 1, 2, 3
- Obtain collateral history from family or caregivers to establish the patient's baseline cognitive function and the acute time course of changes (hours to days) 1
- Perform repeated assessments throughout the day, as delirium symptoms fluctuate substantially within minutes to hours depending on subtype (hyperactive, hypoactive, mixed) 1
- Recognize hypoactive delirium specifically, as it presents with cognitive slowing and sedated appearance, is more common in older adults, carries higher mortality risk, and is frequently missed 1
Identify and Treat Underlying Causes
This is the cornerstone of delirium management and must occur in parallel with symptom control. 1
- Obtain appropriate laboratory studies immediately: complete metabolic panel, complete blood count, urinalysis, chest radiograph, and consider blood cultures if infection suspected 1
- Common precipitating causes to evaluate: infection (especially urinary tract infection and pneumonia), toxic-metabolic disorders, electrolyte and hydration disturbances, hypoxia, organ failure, medications, and intoxication/withdrawal 1
- Review and eliminate delirium-inducing medications: steroids, anticholinergics, benzodiazepines (unless treating alcohol withdrawal), and consider opioid rotation if neurotoxicity suspected 1
- Two or more coexisting causes are frequently present, so continue searching even after identifying one precipitant 1
Non-Pharmacological Interventions (First-Line)
Maximize these interventions before using any pharmacological treatment. 1, 4
- Implement reorientation strategies: frequent verbal reorientation by staff, visible clocks and calendars, family presence when possible 1, 5
- Optimize sleep-wake cycle: minimize nighttime disruptions, ensure adequate daytime light exposure, maintain sleep hygiene 1
- Provide cognitive stimulation: engage patient in conversation, encourage use of glasses and hearing aids 1
- Ensure environmental safety: remove unnecessary tubes and catheters, minimize restraints, provide adequate lighting 1, 5
- Maintain hydration and nutrition, mobilize early when medically appropriate 5
Pharmacological Management (Second-Line)
Moderate Delirium
Use oral antipsychotics only after non-pharmacological interventions have been maximized. 1
- Olanzapine (oral): Start 2.5-5 mg, titrate to symptom control 1, 6
- Quetiapine: Start 12.5-25 mg, titrate as needed 1, 6
- Risperidone: Alternative option with similar efficacy to haloperidol but fewer side effects 6
- Haloperidol (oral): 0.5-1 mg, though atypical antipsychotics have fewer extrapyramidal side effects 1, 6
Severe Delirium with Agitation
When behavioral disturbances pose imminent risk to patient or staff safety, pharmacological intervention may be required as initial treatment to facilitate medical evaluation. 4
- Haloperidol: First-line for severe agitation, can be given IV/IM for rapid control 1, 7
- Olanzapine: Effective alternative for severe symptoms 1
- Chlorpromazine: Use only in bed-bound patients due to hypotensive effects 1
- Add lorazepam (benzodiazepine) only for agitation refractory to high-dose antipsychotics, as therapeutic levels of antipsychotics prevent paradoxical excitation 1
Critical Contraindication
Do NOT use benzodiazepines as initial treatment for delirium unless the patient has alcohol or sedative-hypnotic withdrawal. 1, 5
Special Populations and Situations
End-of-Life Delirium
- Focus on symptom management and family support when delirium results from disease progression in dying patients 1
- Increase doses and/or change routes of administration of neuroleptics and benzodiazepines to ensure adequate symptom control 1
- Consider palliative sedation for refractory delirium after consultation with palliative care specialist 1
Monitoring and Follow-Up
- Measure delirium severity over time using validated scales to ensure appropriate response and resolution 1
- Titrate all symptom-management medications to optimal relief while monitoring for side effects 1
- Implement taper plans for any antipsychotic prescribed, as these should not be continued long-term without reassessment 3
Critical Pitfalls to Avoid
- Missing hypoactive delirium: This subtype appears as lethargy rather than agitation and carries the highest mortality risk 1
- Using benzodiazepines inappropriately: These worsen delirium except in alcohol/sedative withdrawal 1, 5
- Treating symptoms without addressing underlying cause: Delirium is a medical emergency requiring identification of precipitants 1
- Delaying diagnosis: Mortality doubles when delirium is missed 1